Literature DB >> 21502182

The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting.

.   

Abstract

BACKGROUND: Many variations in oocyte and embryo grading make inter-laboratory comparisons extremely difficult. This paper reports the proceedings of an international consensus meeting on oocyte and embryo morphology assessment.
METHODS: Background presentations about current practice were given.
RESULTS: The expert panel developed a set of consensus points to define the minimum criteria for oocyte and embryo morphology assessment.
CONCLUSIONS: It is expected that the definition of common terminology and standardization of laboratory practice related to embryo morphology assessment will result in more effective comparisons of treatment outcomes. This document is intended to be referenced as a global consensus to allow standardized reporting of the minimum data set required for the accurate description of embryo development.

Mesh:

Year:  2011        PMID: 21502182     DOI: 10.1093/humrep/der037

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  367 in total

1.  Oocyte morphology does not affect post-warming survival rate in an egg-cryobanking donation program.

Authors:  Amanda Souza Setti; Rita de Cássia Savio Figueira; Daniela Paes de Almeida Ferreira Braga; Renata Cristina Ferreira; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2011-12-04       Impact factor: 3.412

2.  A randomized clinical trial comparing embryo culture in a conventional incubator with a time-lapse incubator.

Authors:  Kirstine Kirkegaard; Johnny Juhl Hindkjaer; Marie Louise Grøndahl; Ulrik Schiøler Kesmodel; Hans Jakob Ingerslev
Journal:  J Assist Reprod Genet       Date:  2012-03-30       Impact factor: 3.412

3.  Reduced blastocyst formation in reduced culture volume.

Authors:  N De Munck; S Santos-Ribeiro; I Mateizel; G Verheyen
Journal:  J Assist Reprod Genet       Date:  2015-08-21       Impact factor: 3.412

4.  Morphokinetics of embryos developed from oocytes matured in vitro.

Authors:  Mariabeatrice Dal Canto; Paola V Novara; Giovanni Coticchio; Mario Mignini Renzini; Fausta Brambillasca; Claudio Brigante; Elena De Ponti; Rubens Fadini
Journal:  J Assist Reprod Genet       Date:  2015-12-04       Impact factor: 3.412

5.  Choosing GnRH Antagonist Protocol Shows Improved Oocyte and Embryo Quality, Coherent with the Perifollicular Vascularity (PFV) in Assisted Reproductive Techniques.

Authors:  Pavithra Muraleedharan Vengetesh; Amar Ramachandran; Pratap Kumar
Journal:  J Clin Diagn Res       Date:  2015-11-01

6.  Effect of cryopreservation on the properties of human endometrial stromal cells used in embryo co-culture systems.

Authors:  Ivan Bochev; Kalina Belemezova; Atanas Shterev; Stanimir Kyurkchiev
Journal:  J Assist Reprod Genet       Date:  2016-01-12       Impact factor: 3.412

7.  First French live-birth after oocyte vitrification performed before chemotherapy for fertility preservation.

Authors:  J Perrin; J Saïas-Magnan; F Broussais; R Bouabdallah; C D'Ercole; B Courbiere
Journal:  J Assist Reprod Genet       Date:  2016-02-09       Impact factor: 3.412

8.  Implications on IVF patient care of discarding oocytes affected by smooth endoplasmic reticulum aggregates as recommended by the Alpha/ESHRE consensus.

Authors:  Chloë Shaw-Jackson
Journal:  J Assist Reprod Genet       Date:  2015-10-09       Impact factor: 3.412

9.  Ultrastructural markers of quality are impaired in human metaphase II aged oocytes: a comparison between reproductive and in vitro aging.

Authors:  S Bianchi; G Macchiarelli; G Micara; A Linari; C Boninsegna; C Aragona; G Rossi; S Cecconi; S A Nottola
Journal:  J Assist Reprod Genet       Date:  2015-08-15       Impact factor: 3.412

10.  Are extremely high progesterone levels still an issue in IVF?

Authors:  V S Vanni; P Viganò; L Quaranta; L Pagliardini; P Giardina; M Molgora; M Munaretto; M Candiani; E Papaleo
Journal:  J Endocrinol Invest       Date:  2016-08-27       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.